Palo Alto, CA – November 22, 2024 – LVIS Corporation, an innovator in neural information analysis technology, has signed a Memorandum of Understanding (MOU) with Daegu Health College in South Korea to establish a collaboration for training skilled technicians in the use of NeuroMatch®, LVIS’s cutting-edge AI-driven brain diagnostic technology.
This partnership aims to educate and certify 500 clinical pathologists and technicians annually in NeuroMatch technology, beginning in March 2025. Working in collaboration with two additional colleges in South Korea, the initiative will equip students with the specialized skills needed to utilize NeuroMatch in hospital and clinical settings, contributing to the advancement of digital healthcare worldwide.
“This agreement with LVIS is expected to provide students with practical field experience by combining cutting-edge technologies and our university’s educational capabilities,” said President Nam Seong-hee of Daegu Health College. “We will actively support students to contribute to the development of local industries and the medical field by providing them with an innovative educational environment utilizing AI technologies specialized in brain disease diagnosis and treatment.”
Daegu Health College, known for producing highly skilled clinical pathologists and technicians, will integrate NeuroMatch into its curriculum, allowing students to gain expertise in one of the most advanced AI-driven brain diagnostic tools available. By fostering collaboration between education and industry, the program ensures that graduates are well-prepared to meet the demands of modern healthcare.
“Through this partnership, we are not only training the next generation of technicians but also accelerating the adoption of NeuroMatch globally,” said Dr. Jin Hyung Lee, Founder of LVIS Corporation and Associate Professor at Stanford University. “By integrating our technology into education, we are preparing a workforce that will revolutionize the standard of care in neurology.”
This agreement builds on LVIS’s success in South Korea, where the company has already launched NeuroMatch in 10 hospitals and established its first NeuroMatch Center in Daegu. The Center serves as a hub for education and collaboration, providing hands-on learning opportunities and supporting the integration of NeuroMatch technology into clinical practice.
LVIS’s commitment to innovation and collaboration is at the forefront of its mission to modernize neurological diagnostics and care. For more information about NeuroMatch or LVIS Corporation, visit https://lviscorp.com/.
About LVIS Corporation:
LVIS Corporation, headquartered in Palo Alto, California, is a pioneer in the field of neurotechnology. The company’s mission is to improve patient care through innovative technological solutions. With a team of leading experts in neurology, AI, and bioengineering, LVIS is dedicated to pushing the boundaries of what is possible in neurological diagnostics and treatment. The company’s flagship technology, NeuroMatch, is revolutionizing EEG diagnostics and helping restore brain function.
Media Contact:
Amanda Gort, Public Relations Specialist
KCOMM for LVIS Corporation
amanda@kcomm.com (949) 443-9300